Supreme Petrochem / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-04-30Back to SUPREMEPETROCHEM

Revenue

₹1,606 Cr

verified against source

Revenue YoY

3%

reported change

EBITDA

₹253 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: 169 · Watch source sentiment · 2026-04-30Q4 FY26169169
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Supreme Petrochem reported a mixed Q4 FY26 with revenue of ₹1,587 crore (+3% YoY) and EBITDA of ₹253 crore (+75% YoY), driven by higher volumes and better spreads amid stable styrene prices until March. PAT stood at ₹168 crore with EBITDA margins expanding to 15.9%. The quarter benefited from seasonal demand and inventory gains, though management cautioned that the West Asia conflict caused a sharp spike in raw material costs and disrupted supply chains. For FY27, management guided for 8-10% volume growth assuming normalization by Q2, with ABS operating at 65% capacity and EPS Phase 2 commissioned. Key risks include potential inventory losses if styrene prices correct sharply and subdued non-OEM demand due to high prices and labor shortages.

Colored figures show movement against the previous available record.

Guidance to track

  • Management expects 8-10% volume growth in FY27, assuming normalization of global conditions by Q2.
  • Total capex for FY27 is planned at around ₹250 crore, funded through internal accruals.
  • ABS Phase 2 expansion is still targeted for FY28, though dependent on market conditions.
  • X-Mold division expected to achieve 65-70% capacity utilization in FY27, up from ~45% in FY26.

Risks flagged

  • If the West Asia conflict resolves and styrene prices drop sharply, the company may face significant inventory losses.
  • Non-OEM demand has been impacted by high raw material prices, labor unavailability, and gas supply issues, which could persist.
  • The ABS plant operates at only 65% of original capacity due to a critical equipment failure, with no timeline for full restoration.
  • The West Asia conflict and Strait of Hormuz disruption have impacted styrene shipments, though alternative sourcing is in place.

Key quotes

  • We are not entering into contracts at the moment because the situation is so fluid.
  • The non-OEM sector demand has taken a big beating at the moment.
  • If normality returns by June end, second quarter onwards things are normal, then we expect that with the ABS operational we should be able to do 8 to 10% volume growth this year.

Research modules

Go one layer deeper.